Get started
Author

Volha Tryputsen

Observed name: VOLHA TRYPUTSEN
ORCID: 0000-0003-1190-1392
Observed ORCID: 0000-0003-1190-1392
OpenAlex ID: A5030813248
Optimizing Regions-of-Interest Composites for Capturing Treatment Effects on Brain Amyloid in Clinical Trials
2014 · Volha Tryputsen, the Alzheimer's Disease Neuroimaging Initiative, et al. · Journal of Alzheimer s Disease · 19
Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex
2014 · Leah Aluisio, Ian Fraser, et al. · Frontiers in Neuroscience · 9
PDF
Using Fisher's Method to Identify Enriched Gene Sets
2014 · Volha Tryputsen, Javier Cabrera, et al. · Statistics in Biopharmaceutical Research · 5
Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors
2022 · Linda A. Snyder, Rajendra Damle, et al. · Molecular Cancer Therapeutics · 4
PDF
Development Of a Serum Biomarker Panel That Predicts Imminent Risk Of Multiple Myeloma (MM) Progression From Premalignancy
2013 · A Kate Sasser, Tineke Casneuf, et al. · Blood · 3
Therapeutic Potential of EP3 Receptor Antagonists for Treatment of Noninsulin Dependent Diabetes Mellitus across Multiple Preclinical Models
2018 · MATTHEW M. RANKIN, LILI GUO, et al. · Diabetes · 2
Abstract 13403: Data Nuggets for Matching Large Clinical Datasets: Application in a 350,000 Record Perinatal Database
2021 · Volha Tryputsen, Cande V Ananth, et al. · Circulation · 1
Proteomic Profiling Reveals Targetable Pathways in MGUS (SLAMF6, TNFRSF8, TIMP1, TRL2) That May Contribute to Disease Progression
2017 · Tineke Casneuf, Volha Tryputsen, et al. · Blood · 1
Supplementary Figure from Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors
2023 · Linda A. Snyder, Rajendra Damle, et al.
PDF
Supplementary Figure from Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors
2023 · Linda A. Snyder, Rajendra Damle, et al.
Data from Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors
2023 · Linda A. Snyder, Rajendra Damle, et al.
Data from Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors
2023 · Linda A. Snyder, Rajendra Damle, et al.
Abstract 4128: Niraparib shows superior tissue distribution and efficacy in a prostate bone metastasis model compared with other PARP inhibitors
2020 · Linda A. Snyder, Rajendra N. Damle, et al. · Cancer Research
P4–223: On the selection of cognitive and functional markers of brain volume and atrophy
2013 · Eric Yang, Nandini Raghavan, et al. · Alzheimer s & Dementia
P1–353: Optimizing region‐of‐interest composites for capturing treatment effects on amyloid in clinical trials
2013 · Volha Tryputsen, Allitia DiBernardo, et al. · Alzheimer s & Dementia
Works count: 15
Citation count: 44
H-index: 4
I10-index: 1
Year
Topic
Type